ProKidney Reports Q1 GAAP EPS of -$0.14, Beats Estimates; Revenue at $0.23M
ProKidney (PROK) reported a better-than-expected Q1 loss per share and revenue in line with market forecasts. The company's cash reserves declined to $224.9 million as of March 31, 2026, from $270.0 million at the end of December 2025.
Tickers: $PROK
Topics: cash_position financial_results